Bioequivalence Study of Paclitaxel for Injection (Albumin Bound) in Subjects With Breast Cancer
Clinical trial NCT06765590 · RECRUITING
Trial details
- NCT number
- NCT06765590
- Sponsor
- Sichuan Huiyu Pharmaceutical Co., Ltd
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-12
- Primary completion
- 2026-06-12
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.